长寿与创新:心脏再同步疗法在一个100岁的严重心力衰竭患者-一个4年的随访
Ayman Helal1, Ibrahim Antoun2, Rachana Prasad1
1Department of Cardiology, Kettering General Hospital, University Hospitals of Northamptonshire, Kettering, Northamptonshire, UK, nhs.uk.
Case reports in cardiology
|February 13, 2026
概括
心脏再同步疗法 (CRT) 改善了老年心力衰竭患者的结果,这些患者患有左心室缩功能障碍和电力失同. 这份案例报告显示,CRT-P对患有AF,LBBB和缺血性心脏病的100岁老人有好处.
科学领域:
- 心脏病学 心脏病学
- 老年医学 老年医学
- 医疗器械 医疗器械
背景情况:
- 严重的左心室缩功能障碍 (LVSD) 和电力失调经常导致心力衰竭.
- 心脏再同步治疗 (CRT) 是为了改善符合条件的患者的治疗结果而建立的.
- 在老年人中治疗心力衰竭带来独特的挑战.
研究的目的:
- 介绍一个成功的心脏再同步治疗步调 (CRT-P) 植入100岁患者的案例.
- 评估CRT-P的长期疗效和安全性,对具有多种并发症的非老年人进行评估.
- 突出CRT-P在改善极端老年心力衰竭患者生活质量的潜在好处.
主要方法:
- 一个病例报告,是一名100岁的男性患有心房动 (AF),左捆支部阻塞 (LBBB) 和缺血性心脏病.
- 一个CRT-P装置的成功植入.
- 密切的植入后监测和4年的随访.
主要成果:
- 患者在CRT-P植入后经历了显著的症状改善.
- 在4年的随访期内,功能独立性得到维持.
- CRT-P被很好地容忍,没有报告任何重大并发症.
结论:
- 对于患有心力衰竭,LVSD和电动失调的非常老年患者来说,CRT-P可以是一个可行的和有益的治疗选择.
- 这一案例证明了CRT-P提高非老年人的生活质量和功能状态的潜力.
- 仔细的患者选择和监测对于优化这一群体的结果至关重要.
相关概念视频
Heart Failure VI: Adjunct Therapies
399
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
399
Heart Failure II: Pathophysiology
1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure
4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction
958
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
958
Heart Failure Drugs: Diuretics
1.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
Heart Failure V: Medical Management
363
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
363


